0001193125-09-145168 Sample Contracts

SUBLEASE AGREEMENT

Sublease Agreement • July 7th, 2009 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Utah

• Contract Type
  Sublease Agreement
• Filed
  July 7th, 2009
• Company
  Myriad Genetics Inc
• Industry
  In vitro & in vivo diagnostic substances
• Jurisdiction
  Utah

change order. The cost of any change orders that are necessary to comply with applicable building codes and other laws shall be borne by Landlord, unless such change orders are necessitated only because of (1) other change orders requested by Tenant; (2) Tenant Finish Plans; (3) changes to Tenant Finish Plans; or (4) Tenant’s early occupancy to the Building prior to substantial completion of Landlord’s Work. Any change order shall be effective only when set forth on a written change order executed by Landlord, Tenant, and the Base Building General Contractor. By approving a change order, Tenant and Landlord shall agree to a delay in Substantial Completion and to the Target Date, as specified therein, if any.

EMPLOYEE MATTERS AGREEMENT by and between MYRIAD GENETICS, INC. and MYRIAD PHARMACEUTICALS, INC. Dated as of June 30, 2009

Employee Matters Agreement • July 7th, 2009 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Delaware

• Contract Type
  Employee Matters Agreement
• Filed
  July 7th, 2009
• Company
  Myriad Genetics Inc
• Industry
  In vitro & in vivo diagnostic substances
• Jurisdiction
  Delaware

EMPLOYEE MATTERS AGREEMENT (this “Agreement”), dated as of June 30, 2009, by and between Myriad Genetics, Inc., a Delaware corporation (“Myriad”), and Myriad Pharmaceuticals, Inc., a Delaware corporation (“MPI”). Each of Myriad and MPI is herein referred to as a “Party” and collectively, as the “Parties”.

TAX SHARING AGREEMENT

Tax Sharing Agreement • July 7th, 2009 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Delaware

• Contract Type
  Tax Sharing Agreement
• Filed
  July 7th, 2009
• Company
  Myriad Genetics Inc
• Industry
  In vitro & in vivo diagnostic substances
• Jurisdiction
  Delaware

This Tax Sharing Agreement (this “Agreement”) is entered into as of June 30, 2009 between Myriad Genetics, Inc., a Delaware corporation (“Myriad”), and Myriad Pharmaceuticals, Inc., a Delaware corporation and wholly owned subsidiary of Myriad (“MPI” and together with Myriad, the “Parties”). Capitalized terms used in this Agreement and not otherwise defined herein shall have the meanings ascribed to such terms in the Separation and Distribution Agreement, dated as of the date hereof, by and between Myriad and MPI (the “Separation Agreement”).